C eliac disease (CD) is a systemic autoimmune disorder, characterized by a small intestine enteropathy, caused by the ingestion of glutencontaining cereals (wheat, rye, and barley) in genetically predisposed individuals. 1 Almost 1% of the population in Europe and North America has CD. 1, 2 In recent years, population screening studies documented an increase in the prevalence of CD. [1] [2] [3] [4] [5] However, the contribution to this rising prevalence of an increased sensitivity of the diagnostic algorithm, based on the determination of serum IgA class antitransglutaminase antibody (anti-tTG ab) nowadays and IgA anti-native gliadin antibodies (AGA) during the 1980s-1990s, 6 has never been precisely estimated. The aim of this study was to compare the diagnostic performance of IgA anti-tTG with that of IgA AGA in a population CD screening study.
Samples and Methods
We investigated 138 sera samples from school children (5-10 years of age) participating in a CD screening project in Italy during the years 2015-2016. Forty-six of them showed positivity of both IgA antitTG and anti-endomysial antibody (EMA) (overt or potential CD), whereas 92 were IgA anti-tTG and EMA negative (non-CD control subjects).
IgA AGA was analyzed by a commercially available sandwich-type enzyme immunoassay (Eurospital, Trieste, Italy). All sera samples showing IgA AGA level >5.5 arbitrary units/mL were considered positive.
IgA anti-tTG and EMA antibodies were determined using commercially available kits, QUANTA Flash h-tTG IgA (Inova Diagnostics, San Diego, CA) and Nova Lite Monkey Esophagus (Inova Diagnostics), respectively. Total serum IgA concentrations were determined using nephelometric technique and compared with cutoff values for age.
Results
Out of 46 untreated CD sera, 28 samples (61%; 95% CI, 47-75) from 10 males and 18 females (mean age AE SD, The sensitivity, specificity, and positive and negative predictive values of the IgA AGA were 61%, 96%, 87.5%, and 83%, respectively. Based on IgA AGA results, the rate of missed CD cases in the screening project was 39% (95% CI, 25-53).
Discussion
Our study compares the diagnostic performance of the 2 serologic tests mostly used in CD population screening: IgA native AGA (old studies) versus IgA anti-tTG ab (recent studies). As for IgA AGA, a systematic review with meta-analysis on the accuracy of antibody tests for CD diagnosis reported sensitivity ranging from 60.9% to 96%, significantly lower than that of IgA anti-tTG (73.9%-100%). 7 However, all previous reports compared the diagnostic performance of CD antibodies in selected groups of patients, mostly subjects with symptomatic disease. This is the first study to investigate the diagnostic performance of these tests in a sample of the general population. According to our data, almost 40% of IgA tTG-positive children with CD were missed by a screening approach based on IgA AGA as the initial investigation.
Our study also found a significant proportion of falsepositive IgA AGA samples; 4.3% of the control sera samples (anti-tTG and EMA negative) showed IgA AGA positivity. Theoretically, these could be cases of nonceliac gluten sensitivity. However, because of lack of specifically collected clinical information, we could not evaluate this hypothesis in our patients.
This study definitively confirms the higher sensitivity of IgA anti tTG ab test in comparison with IgA AGA to detect CD autoimmunity in screening studies of the general population. These data suggest that the recently observed increase in CD prevalence is a complex phenomenon, partially related to a true increase explained by environmental changes (eg, intestinal infections, the composition of intestinal microbiota), as also shown by longitudinal data in the United States, 8 and a false increase caused by the higher accuracy of the current diagnostic algorithm. Our work quantifies the contribution of this improved accuracy to the observed increase in the prevalence of CD. 
